Scaling advanced cell models is no longer limited by biology - it’s limited by time, staffing, and consistency.
Manual workflows for 2D cultures, iPSCs, and organoids demand significant hands-on effort, often requiring 6–30 hours per week per workflow. This creates bottlenecks in productivity, increases variability, and places pressure on laboratory teams.
This eBook explores how image-guided automated cell culture enables more efficient, standardized, and scalable workflows.
What you’ll learn
- How to reduce hands-on time in cell culture workflows
- Ways to improve consistency and decision-making
- How automation supports 24/7 operation without increased staffing
- Key considerations for scaling 2D, iPSC, and organoid models
- The role of AI and image-guided systems in culture optimization
Why it matters
By reducing manual intervention and standardizing processes, automated systems can improve reproducibility, minimize risk, and free up scientist time for higher-value work.
Download the eBook
Discover how to scale cell culture workflows with greater efficiency and reliability.
About Molecular Devices UK Ltd
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.